1-5 of 5
David M Markusic, PhD
Close
Sort by
Journal Articles

Defining the Risk of Suboptimal AAV8-F9 Vector Delivery in Inhibitor Positive Hemophilia B Mice

David M Markusic, PhD, Brett Palaschak, BA
Journal: Blood
Blood (2016) 128 (22): 3508.
https://doi.org/10.1182/blood.V128.22.3508.3508
Published: 2016
Journal Articles

Clotting Factor VIII Overexpression Shows Signs of ER Stress but Does Not Cause Toxicity upon Gene Transfer

Irene Zolotukhin, MS, Brett Palaschak, BA, David M Markusic, PhD, Roland Herzog, PhD
Journal: Blood
Blood (2015) 126 (23): 3238.
https://doi.org/10.1182/blood.V126.23.3238.3238
Published: 2015
Journal Articles

Immune Response to FIX Is Dependent on Mouse Background Strain and Modulated By TLR4

David M Markusic, PhD
Journal: Blood
Blood (2014) 124 (21): 1479.
https://doi.org/10.1182/blood.V124.21.1479.1479
Published: 2014
Journal Articles

In Vivo Model to Evaluate Loss of Liver-Derived Factor IX Expression Caused by AAV Capsid-Specific CD8+ T Cells

David M Markusic, PhD, Ashley T Martino, Ph.D., Federico Mingozzi, PhD., Katherine A. High, MD, Roland W Herzog, PhD
Journal: Blood
Blood (2012) 120 (21): 2046.
https://doi.org/10.1182/blood.V120.21.2046.2046
Published: 2012
Journal Articles

Suppression of Inhibitor Formation in Protein and Gene Therapy for Hemophilia Using Ex Vivo Expanded Treg

Debalina Sarkar, PhD, David M Markusic, PhD, Cox Terhorst, PhD, Todd Brusko, PhD, Roland W Herzog, PhD
Journal: Blood
Blood (2012) 120 (21): 13.
https://doi.org/10.1182/blood.V120.21.13.13
Published: 2012